Table 2 Immunohistochemical expression results of the tumor nodules in the first cohort
Case no. | Nodule designation | EpCAM% | Sox9% | CK19% |
|---|---|---|---|---|
1 | i ii | 0 0 | 1 0 | 0 0 |
2 | i ii | 0 0 | 0 0 | 0 0 |
3 | i ii iii iv | 1 0 0 0 | 1 1 1 0 | 0 0 1 0 |
4 | i ii | 0 0 | 1 1 | 0 0 |
5 | i ii | 0 0 | 3 1 | 0 0 |
6 | i ii | 0 0 | 3 1 | 0 0 |
7 | i ii | 0 0 | 0 3 | 0 0 |
8 | i ii iii | 0 0 0 | 1 1 2 | 0 0 0 |
9 | i ii | 1 0 | 2 2 | 0 0 |
10 | i ii iii | 0 1 0 | 0 2 1 | 0 1 0 |
11 | i ii | 0 0 | 0 0 | 0 0 |
12 | i ii | 1 0 | 2 1 | 3 0 |
13 | i ii iii | 0 0 0 | 0 0 0 | 0 0 0 |
14 | i ii | 0 0 | 0 1 | 0 1 |
15 | i ii iii | 0 0 0 | 2 1 1 | 0 0 0 |
16 | i ii | 0 0 | 0 1 | 0 0 |
17 | i ii iii | 0 0 0 | 0 1 1 | 0 1 0 |
18 | i ii | 0 0 | 0 0 | 0 0 |
19 | i ii iii | 0 0 0 | 2 0 1 | 1 0 0 |
20 | i ii | 0 0 | 0 0 | 0 0 |
21 | i ii | 0 0 | 0 1 | 0 0 |